INNOSPEC INC.(IOSP)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

INNOSPEC INC. (IOSP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IOSP at 50.5/100 on a 32-signal composite quality model, placing it at rank #1,594 of 2,962 stocks — the bottom half of the AI-ranked universe. IOSP scores in the top quartile across balance sheet strength (75.9). Areas of concern include institutional flow (17.5) and revenue growth (21.4), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), INNOSPEC INC. reports quarterly revenue of $491.4M, net income of $30.8M, an operating margin of 8.1%. Top institutional holders of IOSP by reported 13-F value include BlackRock, Allspring Global Investments, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. IOSP trades on the Nasdaq exchange and files with the SEC under CIK 1054905. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IOSP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for INNOSPEC INC. directly from SEC EDGAR.